Status:

COMPLETED

Combining Registry Data in Haemophilia: TARGET H

Lead Sponsor:

University of Pretoria

Collaborating Sponsors:

Novo Nordisk A/S

Medical Research Council, South Africa

Conditions:

Haemophilia

Eligibility:

MALE

Brief Summary

This is an investigator-initiated, multinational, retrospective, non-interventional pilot study conducted in five haemophilia treatment centres from different geographical regions that maintain a loca...

Detailed Description

The study is conducted in five haemophilia treatment centres (HTCs) from different geographical regions (Algeria, India, Iran, Malaysia and South Africa) that maintain a local or national haemophilia ...

Eligibility Criteria

Inclusion

  • male
  • diagnosis of haemophilia A or B
  • with or without inhibitors
  • no other inherited bleeding disorder
  • active patient record
  • willing and able to provide written consent

Exclusion

  • \- unwilling or unable to provide written consent

Key Trial Info

Start Date :

May 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 30 2015

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03264014

Start Date

May 1 2015

End Date

September 30 2015

Last Update

August 28 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.